• Wittycell
Wittycell
  • Company
    • Strategy
    • Market
    • People
      • Board of Directors
      • Scientific Advisory Board
  • R&D
    • The technological plateforms
    • The pipeline
    • Intellectual Property
  • Products
  • Indications
  • Partnerships
  • Investors
  • News
    • Press Release
    • Meeting and congress
    • Job opportunities
    • Relevant scientific articles
    • Downloads
               

Company

Wittycell is developing novel adjuvant products for therapeutic and prophylactic Vaccines based on the Company’s proprietary technology.
Since its foundation, Wittycell S.A.S. has developed a new family of vaccine adjuvants , which aim to satisfy...

Read more...

Press Release

January 04, 2012

Press #17 : Wittycell clinical trial

Wittycell is proud to announce the initiation  of our first Phase I/IIa clinical trial :
a Phase I double-blind trial to......

Read more...

Download Area

Homepage

Contact

Site Map

Disclaimer

Boosting your Immune System
Designed by Haute Mer